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Benign tracheal stenosis is a challenge in interventional pulmonary disease. Bronchoscopic ethanol injection 
(BEI) is always used in airway stenosis caused by malignant tracheal tumours. The efficacy and safety of BEI in 
benign airway stenosis have not been studied before. To compare safety and efficacy between bronchoscopic 
cryotherapy and BEI combined with bronchoscopic cryotherapy in the treatment of benign tracheal stenosis. A 
retrospective study enrolled 61 patients with tracheal stenosis caused by endotracheal intubation and 
tracheotomy from July 2010 to June 2015. Thirty-three patients who received repeated bronchoscopic 
cryotherapy alone were included in group A, and 29 patients who underwent repeated cryotherapy combined 
with BEI were included in group B. The dyspnoea index and tracheal diameter were collected before and after 
treatment. Efficacy and complications were compared between the two groups. The changes in the tracheal 
diameter and dyspnoea index before and after treatment were significant in both groups (P<0.05). The long-term 
cure rate was higher in group B than in group A (100% vs 84.8%). The average duration of dilated airway 
stability was much shorter in group B than in group A (166±28 days vs 278±32 days, P<0.05). The average 
number of cryotherapy sessions performed in group B was significantly less than in group A (22.1±4.7 vs 34.9±6.5, 
P<0.05). Additionally, complications in group A were rare, and the incidence of complications related to BEI was 
low in group B (mild chest pain, 7.1%; bleeding, 3.6%; and cough, 10.7%). BEI combined with bronchoscopic 
cryotherapy is an effective minimally invasive choice for relieving airway obstruction symptoms. 
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Tracheal stenosis caused by post-intubation care and 
tracheotomy is common [1]. The treatment of this condition has 
always been a challenge due to its complex pathophysiology, 
repeated relapse and various treatment options. Surgical 
procedures have been the main treatments for benign airway 
stenosis in the past, but not all patients seem to benefit from 
surgery [2, 3]. Furthermore, with the rapid development of 
interventional pulmonology, endoscopic procedures have 
become a reliable alternative to improve airway patency and 
avoid resection [4]. Several intervention strategies have been 
used to relieve the symptoms of obstructed airways [5], such as 
balloon dilation, stent placement, laser resection, 
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bronchoscopic ethanol injection (BEI) and bronchoscopic 
cryotherapy. 
Ethanol is a potent sclerosant that can completely destroy 
epithelial or endothelial cells [6, 7]. Ethanol injection via a 
bronchoscope has long been used in the treatment of airway 
stenosis caused by malignant tracheal tumours [8]. Therefore, 
BEI has the potential to promote granulation tissue and fibrotic 
tissue necrosis to improve airway stricture. Bronchoscopic 
cryotherapy, which causes little trauma, is another 
interventional therapy that can induce necrosis in a selected 
tissue and destruction of targeted lesions [9] by repeated 
freeze/thaw cycles. It is one of the techniques available for 
intracavitary therapy of airway stenosis caused by fibrotic 
tissue hyperplasia and granulation [10]. Therefore, on the basis 
of these theories, BEI combined with cryotherapy may have 
the ability to accelerate the necrosis of fibrotic tissue at a 
stenotic site to enlarge a narrow lumen. 
In this retrospective study, we aimed to review the files of 
61 patients with benign tracheal stenosis who underwent 
cryotherapy combined with BEI or bronchoscopic cryotherapy 
alone to compare the safety and efficacy of these two 
procedures. 
Patients and Methods 
Sixty-one patients with benign tracheal stenosis were 
included in this retrospective study. The causes of tracheal 
stenosis were endotracheal intubation and tracheotomy. All 
patients underwent bronchoscopy and dimensional 
reconstruction CT of the neck and chest to identify the location, 
diameter and length of the stenosis. Patient characteristics are 
summarized in Table 1. We divided these patients into two 
groups: the 33 patients who received repeated bronchoscopic 
cryotherapy alone were placed in group A, and the 29 patients 
who underwent repeated BEI combined with bronchoscopic 
cryotherapy were placed in group B. Medical files were 
reviewed at the Department of Respiratory Medicine, Guizhou 
Provincial People’s Hospital from July 2010 to June 2015. We 
focused on the immediate effects, durability, complications 
and long-term cure rate data of the different strategies. This 
study was approved by the Guizhou Provincial People’s 
Hospital Medical Ethics Committee. All patients signed an 
informed consent form. 
The tracheal diameter and dyspnoea index were collected 
before and after treatment. The dyspnoea index was scored on 
the basis of American Thoracic Society dyspnoea rating 
criteria: level 0: normal; level 1: shortness of breath appears 
while walking quickly; level 2: shortness of breath appears 
while walking at an ordinary speed; level 3: stopping normal-
speed walking for shortness of breath; and level 4: shortness 
of breath after mild exercise. 
A flexible bronchoscope (Olympus BF-260) was adopted 
during BEI and cryotherapy. In addition, a transbronchial 
needle aspiration (TBNA) needle (Olympus) was used for 
ethanol injection. A Freeze System cryotherapy machine and 
cryotherapy probe were purchased from ERBE 
Elektromedizin GmbH (Germany). 
All patients inhaled lidocaine before the operation, and then, 
venous infusion of propofol and remifentanil was performed 
during the operation. When the bronchoscope was inserted 
near a stenosis, the TBNA needle was inserted through the 
working channel of the bronchoscope to pierce the mucosa of 
the lesion. Then, 0.2 millilitres of ethanol was injected into 
each lesion site once through the TBNA needle. After all 
narrowed sites were injected, we removed the TBNA needle 
and inserted the cryoprobe with its metal probe. Then, the 
metal probe was touched to the lesion tissue, and repeated 
freeze/thaw cycles were performed at least 3 times at the 
lesion site; each freezing step lasted for 1 minute. BEI and 
cryotherapy were repeated every 4-7 days until the narrow 
airway was dilated and stabilized. Attention was paid to 
reducing the chance of haemorrhage during bronchoscopic 
cryotherapy. To avoid tissue avulsion and bleeding, the probe 
was not be moved until the tissue had completely melted. 
Statistical Analysis 
All analyses were performed using SPSS version 17.0 
(SPSS Inc., Chicago, IL, USA). Measurement data are 
expressed as the mean ± standard deviation (SD). A paired t 
test was performed to determine the statistical significance 
when comparing before and after treatment. For comparisons 
between the two groups, a two-sample t-test was used. P < 
0.05 was considered statistically significant. 
Results 
When comparing some clinical indicators between the two 
groups before interventional therapy, there were no obvious 
differences in the tracheal diameter, dyspnoea index or 
stenosis lengths (Table 1). The lengths of tracheal stenosis in 
groups A and B were 1.41±0.22 cm and 1.37±0.14 cm, 
respectively (P>0.05). The tracheal diameters in groups A and 
B were 5.28±0.28 mm and 5.08±0.24 mm, respectively 
(P>0.05). We compared with dyspnoea index scores between 
group A and group B, and there was no significant difference 
(in group A, the average dyspnoea index was 2.50±0.14; in 
group B, it was 2.52±0.16).  
To evaluate the immediate therapeutic effect of 
bronchoscopic cryotherapy alone and that of BEI combined 
with cryotherapy, changes in the tracheal diameter and 
dyspnoea index before and after treatment were compared 
within each group (Fig. 1). The results showed that diameters 
of the airways in group A enlarged from 5.28±0.28 mm to 6.73 
± 0.26 mm; the enlargement was much greater in group B, 
changing from 5.08±0.24 mm to 7.64±0.29 mm. The dyspnoea  
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Age (Years) 37.8±6.3 35.9±5.5 
Male (Female) 22(11) 19(9) 
Endotracheal intubation 24 22 
Tracheotomy 9 6 
The lengths of the tracheal 
stenosis (cm) 
1.51±0.22 1.37 ±0.14 
tracheal diameters 5.28±0.28cm 5.08±0.24cm 
Dyspnea index 2.50±0.14 2.52±0.16 
The clinical indicators above didn’t have statistical difference between 
the two groups. 
 






  Incidence 24.2% 21.4% 
Chest pain 3 2 
Bleeding 1 1 
Cough 4 3 
Long-term cure rate 84.8% 100% 
Dumon stent implantation 3 0 
surgical resection 2 0 
The clinical indicators above didn’t have statistical difference between 
the two groups. 
 
index scores changed from 2.50 ±0.14 to 1.25±0.13 in group 
A and from 2.52 ±0.16 to 1.17±0.14 in group B. All these 
changes were statistically significant (P＜0.05). 
In addition, the average duration of dilated airway stability 
and the average number of cryotherapy sessions were analysed 
and compared between the two groups during the long follow-
up period. The results indicated that the average duration of 
dilated airway stability was much shorter in group B than in 
group A (166±28 days vs 278±32 days, P<0.05) (Fig. 2). A 
total of 22.1±4.7 cryotherapy sessions were performed in 
group B, which was significantly less than that in group A 
(22.1±4.7 vs 34.9±6.5, P<0.05) (Fig. 3). Up to two years of 
follow-up was performed, and the long-term cure rate in group 
B was 100%. In contrast, the rate was lower in group A (84.8%) 
because five patients needed other treatments due to 
aggravated stenosis. Three of these patients received Dumon 
stent implantation, and two of them underwent surgical 
resection. 
The complications related to cryotherapy in group A 
included mild chest pain in three patients, cough in four 
patients and bleeding in one patient (mild chest pain, 9.1%; 
cough, 12.1%; and bleeding, 3%). In contrast, the 
complications that appeared in group B were considered to be 
related to both cryotherapy and BEI and included mild chest 
pain in two patients, bleeding in one patient and cough in three 
patients (mild chest pain, 7.1%; bleeding, 3.6%; and cough, 
10.7%) (Table 2). In both groups, little bleeding occurred, and 
it was rapidly stopped by intratracheal instillation of 
epinephrine. The cough and chest pain were mild and 







































Figure 1. Tracheal diameter of stenosis compared in two groups before 































Figure 2. Compared the average duration for dilated airways stable 
































Figure 3. Average cryotherapy session performed on each patient were 
compared in Group A and B. *P＜0.05. 
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Discussion 
Tracheal intubation and tracheotomy have important roles 
in the treatment of critically ill patients. However, benign 
fibrotic airway stenosis is the most common complication of 
tracheal intubation and tracheotomy[11]. If the stenosis exceeds 
a certain critical level, severe dyspnoea, which often requires 
emergency treatment, may result in respiratory failure and 
death[12]. Therefore, the treatment of tracheal stenosis is of 
great significance. A long cycle is unavoidable when using 
this method to treat benign and malignant airway stenosis; 
nevertheless, stenosis can easily recur. Given these limitations, 
exploring alternative methods is necessary. Ethanol is 
considered an agent for chemical ablation that is widely used 
in cancers[13]. Injecting ethanol via a bronchoscope has long 
been reported to be effective in the treatment of airway 
stenosis caused by malignant tracheal tumours[8]. In this study, 
we first compared the safety and efficacy of BEI combined 
with cryotherapy with that of bronchoscopic cryotherapy 
alone in benign tracheal stenosis due to tracheal intubation and 
tracheotomy. 
In a series of 61 patients, dyspnoea was severe before 
treatment. By analysing the dyspnoea index, we found that the 
dyspnoea index decreased after interventional treatment in 
both groups. Both interventional strategies could eliminate the 
symptoms of airway obstruction in a short time, suggesting 
that the immediate effects of BEI combined with cryotherapy 
and those of bronchoscopic cryotherapy alone were similar. In 
addition, the incidence of complications in group B (21.1% of 
patients; included mild chest pain, 7.1%; bleeding, 3.6%; and 
cough, 10.7%) was not higher than that in group A (23.2% of 
patients; including mild chest pain, 9.1%; cough, 12.1%; and, 
bleeding, 3%), showing that BEI combined with cryotherapy 
did not increase the risk or discomfort of the patients. In other 
words, this combination was as safe as traditional 
bronchoscopic cryotherapy alone. Based on these results, we 
concluded that BEI combined with cryotherapy was safe in the 
treatment of benign airway stenosis. It is a simple and practical 
interventional procedure to improve symptoms of a 
constricted airway. 
During the treatment of benign airway stenosis, long-term 
patency and persistent effects are required, which always 
affect the choice of interventional procedure. Therefore, in this 
research, we paid considerable attention to the difference in 
long-term efficacy between the two interventional treatments. 
Late outcomes were assessed by patient follow-up visits and 
follow-up bronchoscopy. The average duration for dilated 
airway stability, the tracheal diameter and the average number 
of cryotherapy sessions for each patient were calculated in 
these two groups. Excitingly, the tracheal diameter in group B 
was much larger than that in group A after repeated 
interventional therapy. In addition, restenosis did not recur any 
more frequently in group B. More importantly, the average 
duration for dilated airway stability was significantly shorter 
for patients in group B (166±28 days) than for those in group 
A (278±32 days, P<0.05). Additionally, the patients in group 
B received an average of 22.1±4.7 cryotherapy sessions until 
their airway stenosis was stable, whereas patients in group A 
who underwent bronchoscopic cryotherapy alone needed an 
average of 34.9±6.5 cryotherapy sessions, which was more 
sessions. These long-term follow-up results suggested, to a 
certain extent, that BEI combined with bronchoscopic 
cryotherapy might be more effective than bronchoscopic 
cryotherapy alone in patients with benign tracheal stenosis. 
In our later analysis, the long-term cure rate was compared 
between the two groups. The results showed that the long-term 
cure rate was 100% in group B, which was much higher than 
the rate in group A (84.8%). After treatment with BEI 
combined with cryotherapy, restenosis did not occur again in 
the patients in group B. However, in group A, five patients 
required other interventional treatment (including Dumon 
stent implantation (3 patients) and surgical resection (2 
patients)) due to airway restenosis. According to this evidence, 
we reasonably concluded that BEI combined with cryotherapy 
for benign tracheal stenosis was superior to traditional 
bronchoscopic cryotherapy alone in regard to therapeutic 
effects. 
Conclusions 
The conclusions of this study are as follows: BEI combined 
with bronchoscopic cryotherapy is an effective minimally 
invasive choice for relieving airway obstruction symptoms. In 
some cases, this combination is superior to bronchoscopic 
cryotherapy alone in the treatment of benign airway stenosis 
caused by tracheal intubation and tracheotomy. BEI combined 
with bronchoscopic cryotherapy is safe and effective, and it is 
worthy of clinical application. 
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